• Je něco špatně v tomto záznamu ?

Nasal Immunization Using Chitosan Nanoparticles with Glycoprotein B of Murine Cytomegalovirus

M. Slovakova, S. Janovska, R. Sleha, V. Radochova, A. Hatala, N. Mannova, R. Metelka, L. Pudelka, P. Bostik

. 2024 ; 34 (3) : 663-672. [pub] 20231222

Jazyk angličtina Země Jižní Korea

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006643

The use of nanoparticles as a delivery system for a specific antigen could solve many limitations of mucosal vaccine applications, such as low immunogenicity, or antigen protection and stabilization. In this study, we tested the ability of nasally administered chitosan nanoparticles loaded with glycoprotein B of murine cytomegalovirus to induce an immune response in an animal model. The choice of chitosan nanoparticle type was made by in vitro evaluation of sorption efficiency and antigen release. Three types of chitosan nanoparticles were prepared: crosslinked with tripolyphosphate, coated with hyaluronic acid, and in complex with polycaprolactone. The hydrodynamic size of the nanoparticles by dynamic light scattering, zeta potential, Fourier transform infrared spectroscopy, scanning electron microscopy, stability, loading efficiency, and release kinetics with ovalbumin were evaluated. Balb/c mice were immunized intranasally using the three-dose protocol with nanoparticles, gB, and adjuvants Poly(I:C) and CpG ODN. Subsequently, the humoral and cell-mediated antigen-specific immune response was determined. On the basis of the properties of the tested nanoparticles, the cross-linked nanoparticles were considered optimal for further investigation. The results show that nanoparticles with Poly(I:C) and with gB alone raised IgG antibody levels above the negative control. In the case of mucosal IgA, only gB alone weakly induced the production of IgA antibodies compared to saline-immunized mice. The number of activated cells increased slightly in mice immunized with nanoparticles and gB compared to those immunized with gB alone or to negative control. The results demonstrated that chitosan nanoparticles could have potential in the development of mucosal vaccines.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006643
003      
CZ-PrNML
005      
20240423155425.0
007      
ta
008      
240412s2024 ko f 000 0|eng||
009      
AR
024    7_
$a 10.4014/jmb.2308.08008 $2 doi
035    __
$a (PubMed)38303144
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ko
100    1_
$a Slovakova, Marcela $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic $u University of Pardubice, Faculty of Chemical Technology, Pardubice 53201, Czech Republic
245    10
$a Nasal Immunization Using Chitosan Nanoparticles with Glycoprotein B of Murine Cytomegalovirus / $c M. Slovakova, S. Janovska, R. Sleha, V. Radochova, A. Hatala, N. Mannova, R. Metelka, L. Pudelka, P. Bostik
520    9_
$a The use of nanoparticles as a delivery system for a specific antigen could solve many limitations of mucosal vaccine applications, such as low immunogenicity, or antigen protection and stabilization. In this study, we tested the ability of nasally administered chitosan nanoparticles loaded with glycoprotein B of murine cytomegalovirus to induce an immune response in an animal model. The choice of chitosan nanoparticle type was made by in vitro evaluation of sorption efficiency and antigen release. Three types of chitosan nanoparticles were prepared: crosslinked with tripolyphosphate, coated with hyaluronic acid, and in complex with polycaprolactone. The hydrodynamic size of the nanoparticles by dynamic light scattering, zeta potential, Fourier transform infrared spectroscopy, scanning electron microscopy, stability, loading efficiency, and release kinetics with ovalbumin were evaluated. Balb/c mice were immunized intranasally using the three-dose protocol with nanoparticles, gB, and adjuvants Poly(I:C) and CpG ODN. Subsequently, the humoral and cell-mediated antigen-specific immune response was determined. On the basis of the properties of the tested nanoparticles, the cross-linked nanoparticles were considered optimal for further investigation. The results show that nanoparticles with Poly(I:C) and with gB alone raised IgG antibody levels above the negative control. In the case of mucosal IgA, only gB alone weakly induced the production of IgA antibodies compared to saline-immunized mice. The number of activated cells increased slightly in mice immunized with nanoparticles and gB compared to those immunized with gB alone or to negative control. The results demonstrated that chitosan nanoparticles could have potential in the development of mucosal vaccines.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a chitosan $x chemie $7 D048271
650    12
$a Muromegalovirus $7 D018146
650    _2
$a aplikace intranazální $7 D000281
650    _2
$a slizniční imunita $7 D018928
650    _2
$a imunizace $7 D007114
650    _2
$a adjuvancia imunologická $7 D000276
650    12
$a vakcíny $7 D014612
650    _2
$a imunoglobulin A $7 D007070
650    _2
$a glykoproteiny $7 D006023
650    12
$a nanočástice $x chemie $7 D053758
650    _2
$a myši inbrední BALB C $7 D008807
655    _2
$a časopisecké články $7 D016428
700    1_
$a Janovska, Sylva $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic
700    1_
$a Sleha, Radek $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic $u Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove 50001, Czech Republic
700    1_
$a Radochova, Vera $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic
700    1_
$a Hatala, Alexandra $u University of Pardubice, Faculty of Chemical Technology, Pardubice 53201, Czech Republic
700    1_
$a Mannova, Nikola $u University of Pardubice, Faculty of Chemical Technology, Pardubice 53201, Czech Republic
700    1_
$a Metelka, Radovan $u University of Pardubice, Faculty of Chemical Technology, Pardubice 53201, Czech Republic
700    1_
$a Pudelka, Ludovit $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic
700    1_
$a Bostik, Pavel $u University of Defence, Faculty of Military Health Sciences, Hradec Kralove 50001, Czech Republic $u Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove 50001, Czech Republic
773    0_
$w MED00194027 $t Journal of microbiology and biotechnology $x 1738-8872 $g Roč. 34, č. 3 (2024), s. 663-672
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38303144 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155421 $b ABA008
999    __
$a ok $b bmc $g 2080952 $s 1216410
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 34 $c 3 $d 663-672 $e 20231222 $i 1738-8872 $m Journal of microbiology and biotechnology $n J Microbiol Biotechnol $x MED00194027
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace